WELCOME TO The PHARMACEUTICAL REPORT
Free Drug & Alcohol Program
June 11, 2019
I'm For Real
Enter your details once to access all our information and resources
Expanscience, a French independent pharmaceutical and dermo-cosmetics laboratory, generated revenue of € 274.7 million in 2016, of which 54.3% internationally, and employed 1044 employees.
whitePaper | August 8, 2021
If Pharma is to create a new marketing and sales model that is fit for 2020, it will have to begin by analysing its own value chain to identify opportunities for working more closely with healthcare payers and providers. It will, for example, have to collaborate much more closely with payers (be they governments, health insurers, employers or patients) to ensure that it develops medicines which have real social and economic value.
whitePaper | February 5, 2022
Essential medicine access is one of the main objectives of healthcare systems in and pharmaceutical supply chains
ensure that the right amount of medicine, with acceptable quality, will reach the customers in need
whitePaper | February 24, 2022
The COVID-19 pandemic and resulting economic dislocation revealed long-standing vulnerabilities in our
supply chains. The pandemic’s drastic impacts on demand patterns for a range of medical products including
essential medicines wreaked havoc on the U.S. healthcare system.
whitePaper | April 1, 2021
Every year, the U.S. pharmaceutical industry develops
a variety of new drugs that provide valuable medical
benefits. Many of those drugs are expensive and contribute to rising health care costs for the private sector and
the federal government. Policymakers have considered
policies that would lower drug prices and reduce federal
drug expenditures. Such policies would probably reduce
the industry’s incentive to develop new drugs.
whitePaper | January 12, 2020
Supply chains grow more and more complex every day. In response, manufacturers and shippers have been eagerly exploring digital tools that provide actionable insight into the location and condition of in-transit goods. Although there are many technology options when it comes to building a digital supply chain, one type of solution stands out as the most reliable and cost-effective: cellular.
whitePaper | January 3, 2022
There are many factors that can prevent a patient from being able to obtain the medicine they need, ranging from selective marketing decisions by companies to products being too expensive or pharmacy stock-outs
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE